New Study Shows Adherence to Ulcerative Colitis Medications Is Not Affected by Drug Formulation or Dosing Regimen 
   Poor adherence to medication is a recognized medical problem, costing an estimated $100 billion a year in the United States.(i) New data show that while there is a steady decline in adherence to medications for ulcerative colitis (UC), drug formulation and the number of pills taken each day do not affect long-term adherence. The data were presented today at the annual scientific meeting of the American College of Gastroenterology by University of Chicago researcher Sunanda Kane.

PHARMACEUTICAL FIRM ACTS TO CORRECT MISLEADING SALES PITCHES FOR DRUG 
  A pharmaceutical firm in Piscataway has agreed to spend up to $385,000 correcting what the Food and Drug Administration (FDA) contends were blatantly misleading sales pitches for Dipentum, a drug for ulcerative colitis. The FDA said yesterday a permanent injuction was entered in federal court in Newark against Kabi Pharmacia Inc. and its president, Anders Wiklund, as part of a consent degree signed by the FDA and the company. The injunction was signed by U.S. District Court..

Government adds possible risks to bowel drug label 
  Some users of the irritable-bowel treatment Zelnorm have suffered diarrhea so serious they require hospitalization, and four have died from an intestinal problem, the government said Wednesday. The Food and Drug Administration stressed that it has not proved a link between the intestinal condition, called ischemic colitis, and the drug.But the agency ordered that a precaution about the intestinal condition go on Zelnorm's label, along with a larger warning..

ANTI-REJECTION DRUG TESTED ON AUTOIMMUNE DISEASES 
  University of Pittsburgh Medical Center researchers have begun testing the anti-rejection drug FK506 on patients with ulcerative colitis and Crohn's disease.Pitt has administered FK506 to three such patients since receiving Food and Drug Administration approval last summer."It appears all have had a good response,"said Dr. James C. Reynolds, principal investigator of the study and chief of the division of gastroenterology.
 
 

There are also herbal medicines which can very effectively treat colitis & ulcerative colitis. Boswellia is an Ayurvedic  (Indian traditional medicine) herb, used as a natural alternative to drugs. Many studies have found that the effectiveness of Boswellia is similar and even superior to sulfasalazine based prescription drugs. (Source Wikipedia: http://en.wikipedia.org/wiki/Ulcerative_colitis. 

We recommend taking a 4 months course of our Boswellia Serrata Extract.
 
 

Total of 4 bottles-  of Boswellia - 4 Months course - Taken 2 capusles twice a day.
 
 

There are NO ADDITIONAL CHARGES. Packing & Shipping is absolutely FREE. We will deliver direct to your door to reach within 12 days from the date of ordering. A signature will be required at the time of delivery. You can give us your daytime work address or Post Box address if no one will be present at home to receive the shipment during daytime. 
 

Please use the form below to mail us for any information. We will revert back within 10 hours .